Page 91 - e-book CPG - Bipolar Disorder (full 92 pg) (1)
P. 91

CLINICAL PRACTICE GUIDELINES              MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)




                                    ACKNOWLEDGEMENT
              ACKNOWLEDGEMENT

              ACKNOWLEDGEMENT
                                 ACKNOWLEDGEMENT  DG  would  like  to  express  their  gratitude  and  appreciation  to  the
                                   The  members  of  CPG
            The  members  of  CPG
              ACKNOWLEDGEMENT  DG  would  like  to  express  their  gratitude  and  appreciation  to  the
              following for their contributions:    following for their contributions:
            The  members  of  CPG  DG  would  like  to  express  their  gratitude  and  appreciation  to  the
            ACKNOWLEDGEMENT        ACKNOWLEDGEMENT
                                       Panel of external reviewers who reviewed the draft technically
            The  members  of  CPG  DG  would  like  to  express  their  gratitude  and  appreciation  to  the

              following for their contributions: The  members  of  CPG  DG  would  like  to  express  their  gratitude  and  appreciation  to  the
                Panel of external reviewers who reviewed the draft technically
            following for their contributions: following for their contributions:
                                       Technical Advisory Committee of CPG for their valuable input and feedback
                Panel of external reviewers who reviewed the draft technically  like  to  express  their  gratitude  and  appreciation  to  the
            The  members  of  CPG  DG  would  like  to  express  their  gratitude
                                   The  members  of  CPG  DG  would  and  appreciation  to  the
                Technical Advisory Committee of CPG for their valuable input and feedback
                Technical Advisory Committee of CPG for their valuable input and feedback
                                     Panel of external reviewers who reviewed the draft technically
                                       HTA and CPG Council for approval of the CPG
                Panel of external reviewers who reviewed the draft technically
            following for their contributions:   following for their contributions:
                Health Technology Assessment and Clinical Practice Guidelines Council for approval of
                                       Mr. Mohamad Farhan Huszaimi M. Pajar for analysis
                Health Technology Assessment and Clinical Practice Guidelines Council for approval of and synthesis of evidence
                                     Technical Advisory Committee of CPG for their valuable input and feedback
                Technical Advisory Committee of CPG for their valuable input and feedback the draft technically
                                       Panel of external reviewers who reviewed
                Panel of external reviewers who reviewed the draft technically
                the CPG
                the CPG
                                       Ms. Zamilah Mat Jusoh @ Yusof for the retrieval of evidence
                                     HTA and CPG Council for approval of the CPG
                Health Technology Assessment and Clinical Practice Guidelines Council for approval of
                Technical Advisory Committee of CPG for their valuable input and feedback
                                       Technical Advisory Committee of CPG for their valuable input and feedback
                Ms. Subhiyah Ariffin for the retrieval of evidence
                                       Dr. Ahmad Shamil Semanat for the cover design
                Ms. Subhiyah Ariffin for the retrieval of evidence
                                     Mr. Mohamad Farhan Huszaimi M. Pajar for analysis and synthesis of evidence
                the CPG
                                       HTA and CPG Council for approval of the CPG
                Health Technology Assessment and Clinical Practice Guidelines Council for approval of
                Hanan Mikhael, person of lived experience, on the cover design of the CPG
                                       All those who have contributed directly or
                Hanan Mikhael, person of lived experience, on the cover design of the CPG indirectly to the development of the CPG
                                     Ms. Zamilah Mat Jusoh @ Yusof for the retrieval of evidence
                Ms. Subhiyah Ariffin for the retrieval of evidence
                the CPG
                                       Mr. Mohamad Farhan Huszaimi M. Pajar for analysis and synthesis of evidence
                All those who have contributed directly or indirectly to the development of the CPG
                All those who have contributed directly or indirectly to the development of the CPG

                                     Dr. Ahmad Shamil Semanat for the cover de
                Hanan Mikhael, person of lived experience, on the cover design of the CPG sign
                Ms. Subhiyah Ariffin for the retrieval of evidence
                                       Ms. Zamilah Mat Jusoh @ Yusof for the retrieval of evidence

                  Hanan Mikhael, person of lived experience, on the cover design of the CPG
                                     All those who have contributed directly or indirectly
                All those who have contributed directly or indirectly to the development of the CPG to the development of the CPG
                                       Dr. Ahmad Shamil Semanat for the cover design
                DISCLOSURE STATEMENT    DISCLOSURE STATEMENT
                All those who have contributed directly or indirectly to the development of the CPG
                                       All those who have contributed directly or indirectly to the development of the CPG
            DISCLOSURE STATEMENT

                                   The panel members of both DG and RC had completed disclosure forms. None hold shares

              The  panel  members  of  both  DISCLOSURE STATEMENT
              DISCLOSURE STATEMENT  Development  Group  and  Review  Committee  had  completed
            The  panel  members  of  both  Development  Group  and  Review  Committee  had  completed
              disclosure forms. None hold shares in pharmaceutical firms or act as consultants to such firms.
            DISCLOSURE STATEMENT     in pharmaceutical firms or act as consultants to such firms. Details are available upon request
                                   DISCLOSURE STATEMENT
                                   from the CPG Secretariat.
                                 The panel members of both DG and RC had completed disclosure forms. None hold shares
            The  panel  members  of  both  Development  Group  and  Review  Committee  had  completed
            Details are available upon request from the CPG Secretariat.

              disclosure forms. None hold shares in pharmaceutical firms or act as consultants to such firms.
            Details are available upon request from the CPG Secretariat.

            disclosure forms. None hold shares in pharmaceutical firms or act as consultants to such firms. tails are available upon request
                                 in pharmaceutical firms or act as consultants to such firms. De
                                   The panel members of both DG and RC had completed disclosure forms. None hold shares
              The  panel  members  of  both  Development  Group  and  Review  Committee  had  completed

                                 from the CPG Secretariat.
              Details are available upon request from the CPG Secretariat.
              disclosure forms. None hold shares in pharmaceutical firms or act as consultants to such firms.
                                   in pharmaceutical firms or act as consultants to such firms. Details are available upon request
                                   SOURCE OF FUNDING
                                   from the CPG Secretariat.
                SOURCE OF FUNDING
            Details are available upon request from the CPG Secretariat.
            SOURCE OF FUNDING

                                   The  development  of

              SOURCE OF FUNDING  CPG  on  Management  of  Bipolar  Disorder  (Second  Edition)  was
              The  development  of  the   SOURCE OF FUNDING  the  CPG  on  Management  of  Erectile  Dysfunction  was  supported
            The  development  of  the  CPG  on  Management  of  Bipolar  Disorder  (Second  Edition)  was
                                   SOURCE OF FUNDING
              supported financially mainly by the MoH and partly by the Malaysian Psychiatric Association
            SOURCE OF FUNDING      financially in its entirety by the MoH.
                                 The
            The  development  of  the  CPG  on  Management  of  Bipolar  Disorder  (Second  Edition)  was e  Dysfunction  was  supported
                                     development  of  the  CPG  on  Management  of  Erectil
            (MPA).
              supported financially mainly by the MoH and partly by the Malaysian Psychiatric Association

            (MPA).               financially in its entirety by the MoH.
            supported financially mainly by the MoH and partly by the Malaysian Psychiatric Association
              The  development  of  the  CPG  on  Management  of  Bipolar  Disorder  (Second  Edition)  was
                                   The  development  of  the  CPG  on  Management  of  Erectile  Dysfunction  was  supported

              (MPA).
            supported financially in its entirety by MOH.
                                   financially in its entirety by the MoH.







                                          77
                                          77
                                          77                     44
                                          77
                                          79
                                                               44
                                                                 44
   86   87   88   89   90   91   92